Related Experiment Video

Updated: Aug 7, 2026

Long-term Silencing of Intersectin-1s in Mouse Lungs by Repeated Delivery of a Specific siRNA via Cationic Liposomes. Evaluation of Knockdown Effects by Electron Microscopy
15:55

Long-term Silencing of Intersectin-1s in Mouse Lungs by Repeated Delivery of a Specific siRNA via Cationic Liposomes. Evaluation of Knockdown Effects by Electron Microscopy

Published on: June 21, 2013

Lipid-based systems for the intracellular delivery of genetic drugs

N Maurer1, A Mori, L Palmer

  • 1Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, Canada. nmaurer@interchange.ubc.ca

Molecular Membrane Biology
|May 20, 1999
PubMed

Insights

New lipid-based carriers improve genetic drug delivery. These novel systems protect nucleic acids, enhance circulation time, and enable effective cell transfection for treating diseases like infections and tumors.

Area of Science:

  • Biotechnology
  • Nanotechnology
  • Pharmacology

Background:

  • Current genetic drug delivery systems face challenges with systemic application, including rapid clearance and immune responses.
  • Cationic liposomes and engineered viruses have limitations in circulation stability, target specificity, and transfection efficiency.
  • Effective carriers require properties like small size, neutral charge, serum stability, and RES evasion for disease site accumulation.

Purpose of the Study:

  • To review lipid-based technologies for nucleic acid drug delivery.
  • To introduce a novel carrier system addressing limitations of existing delivery methods.
  • To achieve both prolonged circulation and efficient intracellular delivery of genetic drugs.

Main Methods:

  • Entrapment of plasmid DNA and oligonucleotides into lipid particles.
  • Incorporation of small amounts of positively charged lipids within the particles.
  • Stabilization of lipid particles using polyethylene glycol (PEG) coating.

Main Results:

  • The novel carriers protect nucleic acid drugs from nuclease degradation.
  • Particles exhibit an average diameter of 70 nm.
  • Achieved long circulation lifetimes and demonstrated capability for cell transfection.

Conclusions:

  • The developed lipid-based carriers offer a promising solution for systemic genetic drug delivery.
  • These carriers overcome limitations of rapid clearance and immune responses associated with previous systems.
  • The technology facilitates targeted delivery and enhanced therapeutic efficacy for various diseases.

More Related Videos

Cell Squeezing as a Robust, Microfluidic Intracellular Delivery Platform08:02

Cell Squeezing as a Robust, Microfluidic Intracellular Delivery Platform

Published on: November 8, 2013

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform09:41

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform

Published on: February 25, 2021

Related Concept Videos

Cellular Membranes and Drug Transport01:24

Cellular Membranes and Drug Transport

Drugs must traverse multiple biological barriers, such as multi-layered skin, single-layered intestinal epithelium, and the plasma membrane, to reach their target sites within the body. The plasma membrane, a highly structured composite of phospholipids, carbohydrates, and proteins, is the cell's protective boundary, facilitating selective substance exchange.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
Modified-Release Drug Delivery Systems: Rate-Programmed II01:19

Modified-Release Drug Delivery Systems: Rate-Programmed II

Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Oral Drug Delivery Systems: Continuous-Release Systems01:26

Oral Drug Delivery Systems: Continuous-Release Systems

Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices01:28

Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices

Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...